Doxorubicin and BAY 12–9566 for the Treatment of Osteosarcoma in Dogs: A Randomized, Double-Blind, Placebo-Controlled Study
✍ Scribed by Antony S. Moore; William S. Dernell; Gregory K. Ogilvie; Orna Kristal; Robyn Elmslie; Barbara Kitchell; Steven Susaneck; Robert Rosenthal; Mary K. Klein; Joyce Obradovoich; Alfred Legendre; Tara Haddad; Kevin Hahn; Barbara E. Powers; Darren Warren
- Book ID
- 118094721
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 173 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0891-6640
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## The aim of the study was to assess the efficacy and tolerability of fluoxetine treatment of acral lick dermatitis (ALD) in dogs and to investigate ALD as an animal model of obsessive-compulsive disorder (OCD). Sixty-three dogs with ALD were treated with fluoxetine 20 mg daily, or placebo, for 6
## Background: The efficacy of the nonabsorbable antibiotic rifaximin in patients with active acute or chronic pouchitis is unknown. ## Methods: We performed a placebo-controlled pilot trial to evaluate the efficacy and safety of rifaximin in patients with active pouchitis. eighteen patients with
A prospective, randomized, multicentre, double-blind placebo controlled study is described which compares the ecacy and tolerability of hypericum administered as a concentrated ethanolic extract of St John's wort (ZE117) to patients with mild±moderate depression (ICD-10; F 32 . 0 mild; F 32 . 1 mode